Comments
Loading...
Gossamer Bio Insider Trading Activity | NASDAQ:GOSS | Benzinga
Track the latest Gossamer Bio insider trading activity. Stay informed on recent buys, sells, and market impact for Gossamer Bio stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Gossamer Bio Inc Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
There has been no Insider buying or selling in the last 90 days.
Ownership Statistics for Gossamer Bio Inc
Shares Outstanding
227.221M
Insider Shares Owned
1.571M
Insider Percentage Owned
0.69%
Institutional Shares Held
31.632M
Institutional Percentage Held
13.9%
| Jun 25, 2024 | Richard Aranda | CHIEF MEDICAL OFFICER | -1.91K | $0.66 | -$1.26K | SELL | -0.95% | 199.43K | Jun 24 | View |
| Jun 24, 2024 | Faheem Hasnain | PRESIDENT & CEO | 372.00K | $0.67 | $250.28K | BUY | 7.21% | 5.53M | Jun 21 | View |
| Jun 20, 2024 | Bryan Giraudo | COO/CFO | 100.00K | $0.59 | $59.11K | BUY | 26.32% | 480.01K | Jun 18 | View |
| Jun 20, 2024 | Paul Robert Smith JR | CHIEF COMMERCIAL OFFICER | 25.00K | $0.60 | $15.05K | BUY | ∞ | 25.00K | Jun 17 | View |
| Mar 28, 2024 | Waage Christian | EVP, TECH OPS AND ADMIN | -6.43K | $1.16 | -$7.43K | SELL | -1.05% | 608.16K | Mar 27 | View |
| Mar 28, 2024 | Bryan Giraudo | COO/CFO | -6.43K | $1.16 | -$7.43K | SELL | -1.34% | 472.75K | Mar 27 | View |
| Mar 28, 2024 | Faheem Hasnain | PRESIDENT & CEO | -23.17K | $1.16 | -$26.77K | SELL | -0.45% | 5.16M | Mar 27 | View |
| Mar 19, 2024 | Richard Aranda | CHIEF MEDICAL OFFICER | -4.02K | $1.33 | -$5.34K | SELL | -1.98% | 198.80K | Mar 18 | View |
| Mar 19, 2024 | Caryn Peterson | EVP, REGULATORY AFFAIRS | -4.02K | $1.33 | -$5.34K | SELL | -7.46% | 49.83K | Mar 18 | View |
| Nov 17, 2023 | Sandra Milligan | DIRECTOR | 32.00K | $0.79 | $25.21K | BUY | ∞ | 32.00K | Nov 15 | View |
| Nov 14, 2023 | Bryan Giraudo | COO/CFO | 200.00K | $0.56 | $112.88K | BUY | 71.64% | 479.18K | Nov 13 | View |
| Jun 26, 2023 | Richard Aranda | CHIEF MEDICAL OFFICER | -1.81K | $1.29 | -$2.34K | SELL | -0.90% | 200.11K | Jun 22 | View |
| Apr 05, 2023 | Bryan Giraudo | COO/CFO | 55.00K | $1.02 | $56.09K | BUY | 32.32% | 225.16K | Apr 04 | View |
| Mar 22, 2023 | Waage Christian | EVP, TECH OPS AND ADMIN | 18.50K | $1.20 | $22.14K | BUY | 51.23% | 54.61K | Mar 20 | View |
| Mar 22, 2023 | Bryan Giraudo | COO/CFO | 50.00K | $0.97 | $48.44K | BUY | 41.61% | 170.16K | Mar 20 | View |
| Mar 22, 2023 | Faheem Hasnain | PRESIDENT & CEO | 878.57K | $1.14 | $1.00M | BUY | 23.36% | 4.64M | Mar 20 - Mar 22 | View |
| Mar 20, 2023 | Laura Carter | CHIEF SCIENTIFIC OFFICER | -6.03K | $1.10 | -$6.62K | SELL | -7.33% | 76.26K | Mar 16 | View |
| Mar 20, 2023 | Richard Aranda | CHIEF MEDICAL OFFICER | -7.56K | $1.10 | -$8.30K | SELL | -3.61% | 201.93K | Mar 16 | View |
| Mar 20, 2023 | Caryn Peterson | EVP, REGULATORY AFFAIRS | -7.56K | $1.10 | -$8.31K | SELL | -12.32% | 53.85K | Mar 16 | View |
| Oct 25, 2022 | Caryn Peterson | EVP, REGULATORY AFFAIRS | -4.76K | $12.07 | -$57.43K | SELL | -7.19% | 61.41K | Oct 24 | View |
| Oct 25, 2022 | Laura Carter | CHIEF SCIENTIFIC OFFICER | -4.88K | $12.07 | -$58.87K | SELL | -5.59% | 82.29K | Oct 24 | View |
| Oct 25, 2022 | Richard Aranda | CHIEF MEDICAL OFFICER | -4.76K | $12.07 | -$57.43K | SELL | -2.24% | 207.97K | Oct 24 | View |
| Jul 15, 2022 | Laura Carter | CHIEF SCIENTIFIC OFFICER | 6.93K | $7.21 | $49.99K | BUY | 8.64% | 87.17K | Jul 15 | View |
| Jul 15, 2022 | Waage Christian | EVP, TECH OPS AND ADMIN | 6.93K | $7.21 | $49.99K | BUY | 23.77% | 36.11K | Jul 15 | View |
| Jul 15, 2022 | Bryan Giraudo | COO/CFO | 13.87K | $7.21 | $100.00K | BUY | 13.05% | 120.16K | Jul 15 | View |
| Jul 15, 2022 | Faheem Hasnain | PRESIDENT & CEO | 138.70K | $7.21 | $1000.00K | BUY | 3.83% | 3.76M | Jul 15 | View |
| Jul 05, 2022 | Laura Carter | CHIEF SCIENTIFIC OFFICER | -8.81K | $8.25 | -$72.65K | SELL | -9.89% | 80.23K | Jul 01 | View |
| Jun 23, 2022 | Richard Aranda | CHIEF MEDICAL OFFICER | -1.78K | $6.88 | -$12.23K | SELL | -0.83% | 212.44K | Jun 22 | View |
| May 05, 2022 | Laura Carter | CHIEF SCIENTIFIC OFFICER | -1.26K | $7.20 | -$9.09K | SELL | -1.40% | 89.04K | May 04 | View |
| Mar 24, 2022 | Waage Christian | EVP, TECH OPS AND ADMIN | -10.72K | $8.91 | -$95.59K | SELL | -1.75% | 601.23K | Mar 23 | View |
| Mar 24, 2022 | Faheem Hasnain | PRESIDENT & CEO | -19.04K | $8.91 | -$169.70K | SELL | -0.52% | 3.62M | Mar 23 | View |
| Mar 24, 2022 | Bryan Giraudo | COO/CFO | -10.72K | $8.91 | -$95.59K | SELL | -9.16% | 106.29K | Mar 23 | View |
| Mar 17, 2022 | Laura Carter | CHIEF SCIENTIFIC OFFICER | -5.00K | $8.28 | -$41.41K | SELL | -5.25% | 90.30K | Mar 16 | View |
| Mar 17, 2022 | Caryn Peterson | EVP, REGULATORY AFFAIRS | -6.28K | $8.28 | -$51.98K | SELL | -8.67% | 66.17K | Mar 16 | View |
| Mar 17, 2022 | Richard Aranda | CHIEF MEDICAL OFFICER | -6.28K | $8.28 | -$51.98K | SELL | -2.85% | 214.21K | Mar 16 | View |
| Oct 26, 2021 | Caryn Peterson | EVP, REGULATORY AFFAIRS | -2.38K | $12.25 | -$29.12K | SELL | -3.18% | 72.45K | Oct 25 | View |
| Oct 26, 2021 | Laura Carter | CHIEF SCIENTIFIC OFFICER | -2.38K | $12.25 | -$29.12K | SELL | -2.43% | 95.31K | Oct 25 | View |
| Oct 26, 2021 | Richard Aranda | CHIEF MEDICAL OFFICER | -2.38K | $12.25 | -$29.12K | SELL | -1.07% | 219.97K | Oct 25 | View |
| Mar 25, 2021 | Luisa SalterCid | CHIEF SCIENTIFIC OFFICER | -5.49K | $9.48 | -$52.05K | SELL | -2.60% | 206.06K | Mar 23 | View |
| Mar 25, 2021 | Bryan Giraudo | CHIEF FINANCIAL OFFICER | -5.49K | $9.48 | -$52.05K | SELL | -4.48% | 117.01K | Mar 23 | View |
| Mar 25, 2021 | Waage Christian | EVP & GENERAL COUNSEL | -5.49K | $9.48 | -$52.05K | SELL | -0.89% | 610.42K | Mar 23 | View |
| Oct 14, 2020 | Waage Christian | — | 2.50K | $9.53 | $23.82K | PURCHASE | 9.37% | 29.18K | Oct 14 | View |
| Oct 14, 2020 | Faheem Hasnain | DIRECTOR | 96.52K | $10.36 | $1000.00K | BUY | 2.85% | 3.48M | Oct 14 | View |
| Oct 14, 2020 | Bryan Giraudo | — | 3.00K | $10.01 | $30.04K | PURCHASE | 4.03% | 77.50K | Oct 14 | View |
| Jun 23, 2020 | Bryan Giraudo | — | 2.00K | $12.96 | $25.92K | PURCHASE | 2.76% | 74.50K | Jun 23 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.